Trial
NCT00746954
Buspirone as a Potential Treatment for Recurrent Central Apnea
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
University Hospitals Cleveland Medical Center
Condition
Central Apnea
Intervention
Acetazolamide
Why stopped
Patient recruitment and Funding inadequate to finish trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-14